Additionally, the incidence of MTHFR 223A/V heterozygous and PAI-1 4G/5G heterozygous genotypes was higher in patients with COVID-19 and thrombotic events, and that of FV 506R/Q and F2 20210G/A heterozygotes was lower. Here, MTHFR is linked to COVID-19.